Figure 6.
IFNα differentially impacts on JAK2V617F and CALRm HSC homeostasis. (A) Graphs indicate the means values (solid lines) of the estimated parameters calculated using the mathematic model. (i) Δ* parameters were calculated in heterozygous and homozygous JAK2V617F HSCs and heterozygous CALRm HSCs. Δ*het significantly differs in patients with CALRm MPN vs those having JAK2V617F MPN (Mann-Whitney U test, P = .0031). Δ*het in patients with CALRm MPN is significantly different from Δ*hom of those having JAK2V617F MPN (Mann-Whitney U test, P < .0001). The dotted lines indicate Δ* = 0. Δ* > 0 corresponds to an expansion, and Δ* < 0 corresponds to a depletion of the stem compartment. (ii) Δ*het parameters were calculated in type 1 and type 2 CALRm HSCs. Δ*het significantly differs in patients with type 1 CALRm MPN vs those with type 2 CALRm MPN (Mann-Whitney U test, P = .004). (iii) Inverse ratios of the ɣ* parameter was calculated in heterozygous vs homozygous JAK2V617F HSCs. The 1/ɣ* value can be seen as a relative time spent by cells in the inactive compartment of our model. The 1/ɣ* significantly differs in heterozygous vs homozygous JAK2V617F HSCs (Mann-Whitney U test, P = .027). (B) Proposed mechanism of IFNα in JAK2V617F and CALRm HSCs.

IFNα differentially impacts on JAK2V617F and CALRm HSC homeostasis. (A) Graphs indicate the means values (solid lines) of the estimated parameters calculated using the mathematic model. (i) Δ* parameters were calculated in heterozygous and homozygous JAK2V617F HSCs and heterozygous CALRm HSCs. Δ*het significantly differs in patients with CALRm MPN vs those having JAK2V617F MPN (Mann-Whitney U test, P = .0031). Δ*het in patients with CALRm MPN is significantly different from Δ*hom of those having JAK2V617F MPN (Mann-Whitney U test, P < .0001). The dotted lines indicate Δ* = 0. Δ* > 0 corresponds to an expansion, and Δ* < 0 corresponds to a depletion of the stem compartment. (ii) Δ*het parameters were calculated in type 1 and type 2 CALRm HSCs. Δ*het significantly differs in patients with type 1 CALRm MPN vs those with type 2 CALRm MPN (Mann-Whitney U test, P = .004). (iii) Inverse ratios of the ɣ* parameter was calculated in heterozygous vs homozygous JAK2V617F HSCs. The 1/ɣ* value can be seen as a relative time spent by cells in the inactive compartment of our model. The 1/ɣ* significantly differs in heterozygous vs homozygous JAK2V617F HSCs (Mann-Whitney U test, P = .027). (B) Proposed mechanism of IFNα in JAK2V617F and CALRm HSCs.

Close Modal

or Create an Account

Close Modal
Close Modal